Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1995-04-10
1999-06-08
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
600 38, 514963, A61K 4732, A61K 4742, A61L 3100, A61F 1300
Patent
active
059103167
ABSTRACT:
A method of treatment for impotency is provided. The method involves the administration of nitric oxide by a nitric oxide-releasing agent capable of providing a penile erection-inducing amount of nitric oxide to the corpus cavernosum of the penis of an impotent male animal. Also provided is a nitric oxide delivery means for use in the method.
REFERENCES:
patent: 3153094 (1964-10-01), Reilly
patent: 3826832 (1974-07-01), Anderson et al.
patent: 4127118 (1978-11-01), Latorre
patent: 4265714 (1981-05-01), Nolan et al.
patent: 4482533 (1984-11-01), Keith
patent: 4638079 (1987-01-01), Inskip et al.
patent: 4708854 (1987-11-01), Grinstead
patent: 4801587 (1989-01-01), Voss et al.
patent: 4829991 (1989-05-01), Boeck
patent: 4921683 (1990-05-01), Bedell
patent: 4952289 (1990-08-01), Ciccone et al.
patent: 4954526 (1990-09-01), Keefer
patent: 4985471 (1991-01-01), Ohta et al.
patent: 5039705 (1991-08-01), Keefer et al.
patent: 5059603 (1991-10-01), Rubin
patent: 5087631 (1992-02-01), Shaffer et al.
patent: 5087671 (1992-02-01), Loeppky et al.
patent: 5094815 (1992-03-01), Conboy et al.
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5212204 (1993-05-01), Keefer et al.
patent: 5234956 (1993-08-01), Lipton
patent: 5242391 (1993-09-01), Place et al.
patent: 5366997 (1994-11-01), Keefer et al.
patent: 5380758 (1995-01-01), Stamler et al.
patent: 5389675 (1995-02-01), Christodoulou et al.
patent: 5405919 (1995-04-01), Keefer et al.
patent: 5427797 (1995-06-01), Frostell et al.
patent: 5439938 (1995-08-01), Snyder et al.
Burnett et al., Science 257:401-404 (Jul. 17, 1992).
Gillespie et al., Br. J. Pharmacol. 97: 453P (1989).
Holmquist et al., Acta Physiol. Scand. 141: 441-442 (1991).
Holmquist et al., Acta Physiol. Scand. 143: 299-304 (1991).
Ignarro et al., Nature 347: 131-132 (Sep. 13, 1990).
Ignarro et al., Biochemical and Biophysical Research Communications 170 (No. 2): 843-850 (Jul. 31, 1990).
Kim et al., J. Clin. Invest. 88: 112-118 (Jul. 1991).
Pickard et al., Br. J. Pharmacol. 104: 755-759 (1991).
Rajfer et al., The New England Journal Of Medicine 326 (No. 2): 90-94 (Jan. 9, 1992).
Sjostrand et al., Acta Physiol. Scand. 140: 297-298 (1990).
Stroh, Science News 142: 10-11 (Jul. 4, 1992).
Adams et al., "Electron-Affinic Sensitization," Radiation Research, 67, 9-20 (1976).
Alston et al., "Generation of Nitric Oxide by Enzymatic Oxidation of N-Hydroxy-N-Nitrosamines," J. Biol. Chem., 260 (7), 4069-4074 (1985).
Ames et al., "Uric Acid Provides An Antioxidant Defense in Humans Against Oxidant-And Radical-Caused Aging and Cancer: A Hypothesis," Proc. Natl. Acad. Sci. USA, 78, 6858-6862 (1981).
Andrade et al., "Inhibitors of Nitric Oxide Synthase Selectively Reduce Flow in Tumour-Associated Neovasculature," Br. J. Pharmacol., 107, 1092-1095 (1992).
Andrews et al., "Protection Against Gastric Reperfusion Injury by Nitric Oxide: Role of Polymorhophonuclear Leukocytes," Gastroenterology, 104, A33 (1993).
Aoki et al., "Beneficial Effects of Two Forms of NO Administration in Feline Splanchnic Artery Occlusion Shock," Am. J. Physiol., 258, G275-G281 (1990).
Artysbasheva et al., "Synthesis of 1-Alkoxy-3,3-Dialkyltriazene 2-Oxides from Alkoxyamines and Nitrosoamines," translated from Zhurnal Organicheskoi Khimii (J. Organic Chemistry-U.S.S.R.), 28, (6) 1168-1173 (1987).
Beckman et al., "Apparent Hydroxyl Radical Production by Peroxynitrite: Implications for Endothelial Injury From Nitric Oxide and Superoxide," Proc. Natl. Acad. Sci. USA, 87, 1620-1624 (1990).
Beckman, "The Double-Edged Role of Nitric Oxide in Brain Function and Superoxide-Mediated Injury," J. Developmental Physiol., 15, 53-59 (1991).
Beckman, "Ischaemic Injury Mediator," Nature, 345, 27-28 (1990).
Bedford et al., "Threshold Hypoxia: Its Effect on the Survival of Mammalian Cells Irradiated at High and Low Dose-Rates," Br. J. Radiol., 39, 896-900 (1966).
Bohn et al., "Oxygen and Oxidation Promote the Release of Nitric Oxide from Sydnonimines," J. Cardiovasc. Pharmacol., 14, S6-S12 (1989).
Bonakdar et al., "Continuous-Flow Performance of Carbon Electrodes Modified With Immobilized Fe(II)/Fe(III) Centers," Calanta, 36, 219-225 (1989).
Coleman et al., "Phase I Trial of the Hypoxic Cell Radiosensitizer SR-2508: The Results of the Five to Six Week Drug Schedule," Int. J. Radiat. Oncol. Biol. Phys., 12, 1105-1108 (1986).
Dawson et al., "Nitric Oxide Synthase and Neuronal NADPH Diaphorase Are Identical in Brain and Peripheral Tissues," Proc. Natl. Acad. Sci. USA, 88, 7797-7801 (1991).
DeFeudis, "Endothelium-Dependent Vasorelaxation--A New Basis for Developing Cardiovascular Drugs," Drugs of Today, 24, (2), 103-115 (1988).
DeGraff et al., "Evaluation of Nitroimidazole Hypoxic Cell Radiosensitizers in a Human Tumor Cell Line High in Intracellular Glutathione," I. J. Radiation Oncology Biol. Phys., 16, 1021-1024 (1989).
DeLuca et al., "Parenteral Drug-Delivery Systems," in Pharmaceutics and Pharmacy Practice (Banker et al., eds.), 238-250 (J.B. Lippincott Co., Philadelphia, PA) (1982).
Drago et al., "The Reaction of Nitrogen(II) Oxide with Various Primary and Secondary Amines," J. Am. Chem. Soc., 83, 1819-1822 (1961).
Drago, "Reactions of Nitrogen(II) Oxide," in Free Radicals in Organic Chemistry, Advances in Chemistry Series No. 36, 143-149 (American Chemical Society, Washington, DC) (1962).
Fast et al., "Nitric Oxide Production by Tumor Targets in Response to TNF: Paradoxical Correlation With Susceptibility to TNF-Mediated Cytotoxicity Without Direct Involvement in the Cytotoxic Mechanism," J. Leukocyte Biol., 52, 255-261 (1992).
Feelisch et al., "On the Mechanism of NO Release from Sydnonimines," J. Cardiovasc. Pharmacol., 14, S13-S22 (1989).
Feelisch, "The Biochemical Pathways of Nitric Oxide Formation from Nitrovasodilators: Appropriate Choice of Exogenous NO Donors and Aspects of Preparation and Handling of Aqueous NO Solutions," J. Cardiovasc. Pharmacol., 17, S25-S33 (1991).
Feldman et al., "The surprising life of nitric oxide," Chemical & Engineering News, 71, 26-38 (1993).
Filep et al., "Nitric Oxide Modulates Vascular Permeability in the Rat Coronary Circulation," Br. J. Pharmacol., 108, 323-326 (1993).
Fujitsuka et al., "Nitrosohydroxylamines," Chem. Abstracts, 82, 31108P (1975).
Furchgott, "The Role of Endothelium in the Responses of Vascular Smooth Muscle to Drugs," Ann. Rev. Pharmacol. Toxicol., 24, 175-97 (1984).
Gambassi et al., "Ischemia-Reperfusion Injury and Histamine Release in Isolated Perfused Guinea-Pig Heart: Effects of Nitric Oxide Generators," Pharmacological Research, 25, 11-12 (1992).
Garg et al., "Nitric Oxide-Generating Vasodilators Inhibit Mitogenesis and Proliferation of Balb/C3T3 Fibroblasts By A Cylic GMP-Independent Mechanism," Biochem. and Biophys. Res. Comm., 171, 474-479 (1990).
Gatenby et al., "Oxygen Distribution in Squamous Cell Carcinoma Metastases and its Relationship to Outcome of Radiation Therapy," I. J. Radiation Oncology Biol. Phys., 14, 831-838 (1988).
Gehlen et al., "Uber Reaktionen und Eigenschaften des Stickoxyds und seiner Verbindungen (II.Mitteil): Zur Kenntnis der Salze der Stickoxyd-schwefligen Saure," Berichte d. D. Chem. Gesellschaft, LXV, 1130-1140 (1932). ("Reactions and properties of nitric oxide and its compounds. II. The salts of the nitric oxide compound of sulfurous acid," Chemical Abstracts, 26, 4764-65.)
Gelvan et al., "Cardiac Reperfusion Damage Prevented by a Nitroxide Free Radical, " Proc. Natl. Acad. Sci. USA, 88, 4680-4684 (1991).
Granger, "Role of Xanthine Oxidase and Granulocytes in Ischemia-Reperfusion Injury," Am. J. Physiol., 255, H1269-H1275 (1988).
Hall, "The Oxygen Effect and Reoxygenation," in Radiobiology for the Radiologist (4th ed.), 133-164 (J.P. Lippincott Co., Philadelphia) (1994).
Hall et al., "Extreme Hypoxia; Its Effect on the Survival of Mammalian Cells Irradiated at High and Low Dose-Rates," Br. J. Radiol., 39, 302-307 (1966).
Halliwell et al., "Oxygen Toxicity, Oxygen Radicals, Transition Metals and Disease," Biochem. J., 219, 1-14 (1984).
Halliwell et al., "Biologically Relevant Metal Ion-Dependent Hydroxyl Radical Generation," FEBS, 307, 108-112
Doherty Paul C.
Hanamoto Mark S.
Keefer Larry K.
Place Virgil A.
Saavedra Joseph E.
Kulkosky Peter F.
The United States of America as represented by the Department o
Vivus Inc.
LandOfFree
Use of nitric oxide-releasing agents to treat impotency does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nitric oxide-releasing agents to treat impotency, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nitric oxide-releasing agents to treat impotency will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1682182